Pulse Biosciences
PLSE
58 hedge funds and large institutions have $76M invested in Pulse Biosciences in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 4 closing their positions.
135% more call options, than puts
Call options by funds: $845K | Put options by funds: $360K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
6% more capital invested
Capital invested by funds: $71.8M → $76M (+$4.13M)
4% more funds holding
Funds holding: 56 → 58 (+2)
0.42% more ownership
Funds ownership: 12.03% → 12.45% (+0.42%)
10% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tygh Capital Management
Portland,
Oregon
|
+$3.74M |
| 2 |
BlackRock
New York
|
+$2.02M |
| 3 |
Two Sigma Investments
New York
|
+$1.92M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$878K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$811K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.55M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$1.25M |
| 3 |
GAM
Griffin Asset Management
New York
|
-$846K |
| 4 |
Morgan Stanley
New York
|
-$448K |
| 5 |
D.E. Shaw & Co
New York
|
-$296K |
PLSE Hedge Fund Activity: Q1 2021 in Review
58 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2021, worth a combined $76M — up 5.8% from $71.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PLSE positions and 4 closed out — a net gain of 2 holders — while 18 added to existing stakes and 20 trimmed.
The largest buyer was Tygh Capital Management, opening a new position worth an estimated $3.74M. The largest seller was Invesco, exiting entirely with an estimated $1.55M sold.
- 58 institutional investors held Pulse Biosciences (PLSE) as of Q1 2021, up from 56 in Q4 2020.
- Funds reported $76M of Pulse Biosciences stock for Q1 2021, up 5.8% quarter-over-quarter.
- 6 funds opened new Pulse Biosciences positions in Q1 2021 and 4 closed out, a net change of +2 holders.
- The largest Pulse Biosciences buyer in Q1 2021 was Tygh Capital Management, an estimated $3.74M added.
- The largest Pulse Biosciences seller in Q1 2021 was Invesco, an estimated $1.55M sold.
Based on aggregated 13F filings for Q1 2021.